1. The frequency (0-5-150 Hz) and calcium dependence (0-5-2-0 mM) of the effects of the nicotinic antagonist tubocurarine (0f2 /uM) on acetylcholine (ACh) liberation from motor nerve terminals has been examined using binomial analysis of quantal transmitter release. 5. Binomial analysis revealed that all the changes in EPC quantal content associated with both nicotinic antagonists were due to changes in the size of the pool of quanta in the nerve terminal available for immediate release with no effect on the probability of release of an individual quantum. Stertz, Peper, Chau & Wilson, 1973;Glavinovic, 1979c; Magleby, Pallotta & Zhang, 1990). This is manifest in twitch tension Terrar, 1981;Gibb & Marshall, 1984 L. Tian, C. Prior, J. Dempster and I. C. Marshall colleagues (for reviews see Bowman, Gibb, Harvey & Marshall, 1986;Bowman, Marshall, Gibb & Harborne, 1988;Bowman, Prior & Marshall, 1990) have contended that tetanic fade and EPP or EPC amplitude run-down are consequences of tubocurarine inhibiting a nicotinic ACh autoreceptor located on the motor nerve terminal. It is proposed that these putative receptors form part of a positive-feedback system, activation of which by ACh enhances the mobilization and release of ACh during highfrequency motor nerve stimulation. This conclusion is based largely on the ability to detect electrophysiologically a decrease in the quantal release of ACh from motor nerve terminals towards the latter part of high-frequency bursts of motor nerve stimulation . On the other hand, it has been reported that tubocurarine can increase, rather than decrease, ACh release from rat (Wilson, 1982;Wilson & Thomsen, 1991), cat (Blaber, 1970;, frog (Matzner, Parnas & Parnas, 1988) and mouse (Ferry & Kelly, 1988) (Wilson, 1982;Wilson & Thomsen, 1991 have attributed the tubocurarine-induced increase of quantal content, and subsequent increased run-down of EPPs, to a frequency-dependent action of tubocurarine on a negativefeedback motor nerve terminal nicotinic ACh autoreceptor. Blaber (1973) also reported that tubocurarine increased the fractional release of ACh during high-frequency nerve stimulation, although in this study the initial quantal content was not measured. Blaber (1973) proposed that the phenolic moieties of tubocurarine were responsible for its ability to increase fractional release, as trimethyltubocurarine did not increase release. He suggested that these phenolic groups, absent in trimethyltubocurarine, were responsible for the enhancement of the fractional release of ACh, either by increasing the stimulus-evoked influx of calcium ions into the nerve terminal or by increasing the activity of intracellular calcium ions.In an attempt to shed more light on the prejunctional effects of tubocurarine at the neuromuscular junction, we have studied the frequency-and calcium-dependent effects of tubocurarine on the quantal release of ACh from motor nerve terminals. Quantal ACh release at a range of motor nerve stimulation frequencies (0-5-150 Hz) has been determined from the amplitud...